Edwards Lifesciences Corp (EW)
88.64
+0.89
(+1.01%)
USD |
NYSE |
Apr 24, 14:34
Edwards Lifesciences Cash from Operations (Quarterly): 136.60M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 136.60M |
| September 30, 2023 | 411.50M |
| June 30, 2023 | 33.60M |
| March 31, 2023 | 314.10M |
| December 31, 2022 | 282.80M |
| September 30, 2022 | 309.90M |
| June 30, 2022 | 332.20M |
| March 31, 2022 | 293.30M |
| December 31, 2021 | 373.60M |
| September 30, 2021 | 531.90M |
| June 30, 2021 | 526.10M |
| March 31, 2021 | 300.50M |
| December 31, 2020 | 399.80M |
| September 30, 2020 | 216.10M |
| June 30, 2020 | 231.30M |
| March 31, 2020 | 207.10M |
| December 31, 2019 | 402.90M |
| September 30, 2019 | 437.30M |
| June 30, 2019 | 341.20M |
| March 31, 2019 | 1.50M |
| December 31, 2018 | 292.90M |
| September 30, 2018 | 342.30M |
| June 30, 2018 | 140.20M |
| March 31, 2018 | 151.30M |
| December 31, 2017 | 363.90M |
| Date | Value |
|---|---|
| September 30, 2017 | 310.80M |
| June 30, 2017 | 197.70M |
| March 31, 2017 | 128.30M |
| December 31, 2016 | 201.10M |
| September 30, 2016 | 205.90M |
| June 30, 2016 | 190.30M |
| March 31, 2016 | 107.10M |
| December 31, 2015 | 103.80M |
| September 30, 2015 | 202.50M |
| June 30, 2015 | 170.10M |
| March 31, 2015 | 73.30M |
| December 31, 2014 | 93.20M |
| September 30, 2014 | 12.20M |
| June 30, 2014 | 778.00M |
| March 31, 2014 | 138.90M |
| December 31, 2013 | 111.30M |
| September 30, 2013 | 132.20M |
| June 30, 2013 | 128.10M |
| March 31, 2013 | 101.10M |
| December 31, 2012 | 114.70M |
| September 30, 2012 | 131.30M |
| June 30, 2012 | 146.80M |
| March 31, 2012 | -30.70M |
| December 31, 2011 | 93.40M |
| September 30, 2011 | 115.40M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
33.60M
Minimum
Jun 2023
531.90M
Maximum
Sep 2021
320.09M
Average
314.10M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp | 1.528B |
| Boston Scientific Corp | 957.00M |
| Align Technology Inc | 46.90M |
| Abbott Laboratories | 3.038B |
| Steris PLC | 291.24M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 14.10M |
| Cash from Financing (Quarterly) | -413.20M |
| Free Cash Flow | 629.50M |
| Free Cash Flow Per Share (Quarterly) | 0.0577 |
| Free Cash Flow to Equity (Quarterly) | 34.80M |
| Free Cash Flow to Firm (Quarterly) | 35.00M |
| Free Cash Flow Yield | 1.17% |